Page last updated: 2024-08-26

nicotine and minocycline

nicotine has been researched along with minocycline in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's4 (40.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Soory, M; Suchak, A1
Mooney, M; O'Malley, SS; Sofuoglu, M; Waters, AJ1
Ding, Y; Li, C; Wang, Q; Wu, S; Xu, P; Yu, A; Zhang, X; Zhang, Z; Zhu, W1
Cano, M; Gad, M; Green, KN; Leslie, FM; Linker, KE; Tawadrous, P; Wood, MA1
Farokhi, N; Motaghinejad, M; Motevalian, M; Safari, S1

Trials

1 trial(s) available for nicotine and minocycline

ArticleYear
Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 92, Issue:1

    Topics: Adult; Affect; Anti-Infective Agents; Attention; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Minocycline; Nicotine; Nicotinic Agonists; Psychomotor Performance; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires

2009

Other Studies

9 other study(ies) available for nicotine and minocycline

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Effects of alkaline phosphatase and its inhibitor levamisole on the modulation of androgen metabolism by nicotine and minocycline in human gingival and oral periosteal fibroblasts.
    Archives of oral biology, 2003, Volume: 48, Issue:1

    Topics: Adult; Alkaline Phosphatase; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Gas Chromatography-Mass Spectrometry; Gingiva; Humans; Levamisole; Middle Aged; Minocycline; Nicotine; Periosteum; Testosterone

2003
Spinal microglial P2X4 receptor-brain-derived neurotrophic factor signaling regulates nicotine withdrawal-induced hyperalgesia.
    Neuroreport, 2017, Apr-12, Volume: 28, Issue:6

    Topics: Analgesics, Non-Narcotic; Animals; Brain-Derived Neurotrophic Factor; Calcium-Binding Proteins; Disease Models, Animal; Hot Temperature; Hyperalgesia; Male; Microfilament Proteins; Microglia; Minocycline; Nicotine; Nicotinic Agonists; Pain Threshold; Rats, Sprague-Dawley; Receptors, Purinergic P2X4; Spinal Cord; Substance Withdrawal Syndrome

2017
Microglial activation increases cocaine self-administration following adolescent nicotine exposure.
    Nature communications, 2020, 01-16, Volume: 11, Issue:1

    Topics: Aminopyridines; Animals; Chemokine CX3CL1; Cocaine; Disease Models, Animal; Drug-Seeking Behavior; Electronic Nicotine Delivery Systems; Female; Gene Expression Regulation; Male; Microglia; Minocycline; Nicotine; Phenotype; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reinforcement, Psychology; Reward; Self Administration; Synaptophysin

2020
Molecular, histological and behavioral evidences for neuroprotective effects of minocycline against nicotine-induced neurodegeneration and cognition impairment: Possible role of CREB-BDNF signaling pathway.
    Behavioural brain research, 2020, 05-27, Volume: 386

    Topics: Animals; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hippocampus; Lipid Peroxidation; Male; Minocycline; Neurodegenerative Diseases; Neuroprotection; Neuroprotective Agents; Nicotine; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Superoxide Dismutase

2020